May 08, 2024 08:44 (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
SC warns influencers, celebrities of action if found liable for endorsing misleading ads | Husband stabs estranged wife inside Kolkata cafe, chases and kills her on road | Haryana govt loses majority, 3 Independent MLAs withdraw support | Modi accuses Sonia Gandhi of 'appeasement politics', latter returns jibe saying BJP promotes 'hatred' | Election Commission asks X to remove 'derogatory' post by Karnataka BJP
Jubilant Life Sciences receives ANDA approval for Levofloxacin Tablets

Jubilant Life Sciences receives ANDA approval for Levofloxacin Tablets

New Delhi, June 23 (IBNS) Jubilant Life Sciences Ltd, an integrated global Pharmaceuticals and Life Sciences Company, has received Abbreviated New Drug Application (ANDA) final approval from the US Food and Drug Administration (US FDA) for Levofloxacin Tablets, 250mg and 500mg, the generic version of Levaquin Tablets (of Ortho-McNeil), which is used for the treatment of adults with infections such as pneumonia, bacterial sinusitis, chronic bronchitis, skin and skin structure infections, chronic bacterial prostatitis, urinary tract infections and inhalational anthrax.